The term pharmacogenetics has been being used since 1959.1 Pharmacogenetics was first utilized corresponding to phenotypic variety in digestion and reaction to specific medications. This was settled to be a typical marvel on account of some medication medicines before the finish of the 1950s.2–4 After just restricted advancement during the 1960s and 1970s, a mix of improved logical techniques, increasingly broad medication improvement projects and human quality cloning brought about the hereditary premise of this phenotypic variety getting much better comprehended during the 1980s. As quality cloning progressed to sequencing of the whole human genome, the term pharmacogenomics, which was first utilized in 1997,5 began to be utilized notwithstanding pharmacogenetics.
Research Article: Pharmacoeconomics: Open Access
Research Article: Pharmacoeconomics: Open Access
Research Article: Pharmacoeconomics: Open Access
Research Article: Pharmacoeconomics: Open Access
Research Article: Pharmacoeconomics: Open Access
Research Article: Pharmacoeconomics: Open Access
Review Article: Pharmacoeconomics: Open Access
Review Article: Pharmacoeconomics: Open Access
Case Report: Pharmacoeconomics: Open Access
Case Report: Pharmacoeconomics: Open Access
Posters & Accepted Abstracts: Pharmacoeconomics: Open Access
Posters & Accepted Abstracts: Pharmacoeconomics: Open Access
Posters & Accepted Abstracts: Journal of Bioprocessing & Biotechniques
Posters & Accepted Abstracts: Journal of Bioprocessing & Biotechniques
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Keynote Forum: Pharmaceutical Regulatory Affairs: Open Access
Keynote Forum: Pharmaceutical Regulatory Affairs: Open Access
Pharmacoeconomics: Open Access received 95 citations as per Google Scholar report